Health Empire Corporation Public Company Limited Logo

Health Empire Corporation Public Company Limited

HEMP.BK

(1.0)
Stock Price

3,68 THB

-119.05% ROA

-47.09% ROE

-2.92x PER

Market Cap.

1.405.760.000,00 THB

4.71% DER

0% Yield

-4407.51% NPM

Health Empire Corporation Public Company Limited Stock Analysis

Health Empire Corporation Public Company Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Health Empire Corporation Public Company Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (5%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 PBV

The stock's PBV ratio (1.38x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

4 ROE

Negative ROE (-41.95%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-120.26%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-3) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Health Empire Corporation Public Company Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Health Empire Corporation Public Company Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Health Empire Corporation Public Company Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Health Empire Corporation Public Company Limited Revenue
Year Revenue Growth
2003 1.456.105.161
2004 1.547.019.874 5.88%
2005 1.766.001.805 12.4%
2006 1.161.788.229 -52.01%
2007 711.513.733 -63.28%
2008 673.337.648 -5.67%
2009 532.308.317 -26.49%
2010 978.109.577 45.58%
2011 534.032.661 -83.16%
2012 525.736.212 -1.58%
2013 463.048.414 -13.54%
2014 407.484.823 -13.64%
2015 371.451.763 -9.7%
2016 306.170.155 -21.32%
2017 253.655.262 -20.7%
2018 209.129.605 -21.29%
2019 128.319.283 -62.98%
2020 93.297.159 -37.54%
2021 89.502.626 -4.24%
2022 95.845.744 6.62%
2023 13.326.908 -619.19%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Health Empire Corporation Public Company Limited Research and Development Expenses
Year Research and Development Expenses Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Health Empire Corporation Public Company Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 144.615.828 100%
2010 128.112.157 -12.88%
2011 99.110.212 -29.26%
2012 90.919.235 -9.01%
2013 85.625.010 -6.18%
2014 57.630.423 -48.58%
2015 67.290.590 14.36%
2016 72.890.487 7.68%
2017 59.315.085 -22.89%
2018 55.280.473 -7.3%
2019 45.079.445 -22.63%
2020 37.620.216 -19.83%
2021 80.303.952 53.15%
2022 82.338.769 2.47%
2023 51.475.144 -59.96%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Health Empire Corporation Public Company Limited EBITDA
Year EBITDA Growth
2003 388.990.479
2004 177.139.527 -119.6%
2005 95.169.845 -86.13%
2006 -341.960.012 127.83%
2007 -277.810.788 -23.09%
2008 -47.736.762 -481.96%
2009 -11.003.365 -333.84%
2010 91.695.621 112%
2011 61.346.947 -49.47%
2012 45.242.920 -35.59%
2013 117.734.796 61.57%
2014 44.610.789 -163.92%
2015 -22.561.049 297.73%
2016 -75.817.953 70.24%
2017 -42.441.374 -78.64%
2018 -47.810.606 11.23%
2019 -40.829.525 -17.1%
2020 -7.089.672 -475.9%
2021 -11.969.807 40.77%
2022 -43.220.710 72.31%
2023 -12.849.244 -236.37%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Health Empire Corporation Public Company Limited Gross Profit
Year Gross Profit Growth
2003 876.588.006
2004 913.330.643 4.02%
2005 1.038.342.355 12.04%
2006 613.673.704 -69.2%
2007 284.421.828 -115.76%
2008 286.052.228 0.57%
2009 211.655.867 -35.15%
2010 498.118.782 57.51%
2011 219.729.773 -126.7%
2012 201.053.887 -9.29%
2013 189.432.874 -6.13%
2014 163.987.410 -15.52%
2015 115.973.724 -41.4%
2016 74.086.141 -56.54%
2017 61.533.220 -20.4%
2018 51.395.348 -19.73%
2019 21.949.110 -134.16%
2020 22.166.603 0.98%
2021 38.748.034 42.79%
2022 33.084.330 -17.12%
2023 6.612.112 -400.36%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Health Empire Corporation Public Company Limited Net Profit
Year Net Profit Growth
2003 287.722.571
2004 100.037.996 -187.61%
2005 4.336.533 -2206.87%
2006 -461.792.921 100.94%
2007 -407.496.893 -13.32%
2008 -291.397.878 -39.84%
2009 -186.301.688 -56.41%
2010 -56.041.635 -232.43%
2011 21.576.924 359.73%
2012 5.966.133 -261.66%
2013 73.539.850 91.89%
2014 6.474.828 -1035.78%
2015 -60.470.120 110.71%
2016 -98.364.980 38.52%
2017 -69.436.953 -41.66%
2018 -65.305.881 -6.33%
2019 -64.746.345 -0.86%
2020 -45.627.937 -41.9%
2021 -61.424.497 25.72%
2022 -475.835.549 87.09%
2023 -28.082.444 -1594.42%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Health Empire Corporation Public Company Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 7
2004 3 -100%
2005 0 0%
2006 -12 100%
2007 -10 -10%
2008 -6 -100%
2009 -4 -66.67%
2010 -1 -200%
2011 0 0%
2012 0 0%
2013 1 0%
2014 0 0%
2015 0 0%
2016 -1 0%
2017 -1 0%
2018 0 0%
2019 0 0%
2020 -1 0%
2021 0 0%
2022 -1 100%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Health Empire Corporation Public Company Limited Free Cashflow
Year Free Cashflow Growth
2003 503.226.531
2004 336.599.053 -49.5%
2005 476.939.885 29.43%
2006 113.925.409 -318.64%
2007 16.613.491 -585.74%
2008 -75.396.093 122.03%
2009 23.145.694 425.75%
2010 27.175.227 14.83%
2011 18.239.303 -48.99%
2012 7.597.857 -140.06%
2013 10.043.161 24.35%
2014 -2.889.818 447.54%
2015 -77.792.878 96.29%
2016 -85.558.612 9.08%
2017 -31.834.758 -168.76%
2018 -26.665.448 -19.39%
2019 -6.089.513 -337.89%
2020 -10.288.404 40.81%
2021 -91.280.587 88.73%
2022 -74.886.993 -21.89%
2023 -3.315.397 -2158.76%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Health Empire Corporation Public Company Limited Operating Cashflow
Year Operating Cashflow Growth
2003 503.226.531
2004 336.599.053 -49.5%
2005 476.939.885 29.43%
2006 113.925.409 -318.64%
2007 16.613.491 -585.74%
2008 -56.830.526 129.23%
2009 33.337.309 270.47%
2010 41.032.022 18.75%
2011 33.609.588 -22.08%
2012 19.585.027 -71.61%
2013 27.478.028 28.72%
2014 19.272.144 -42.58%
2015 -49.123.549 139.23%
2016 -71.301.739 31.1%
2017 -31.555.878 -125.95%
2018 -23.651.022 -33.42%
2019 -5.994.511 -294.54%
2020 -8.684.737 30.98%
2021 -38.455.387 77.42%
2022 -36.470.523 -5.44%
2023 -1.761.397 -1970.55%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Health Empire Corporation Public Company Limited Capital Expenditure
Year Capital Expenditure Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 18.565.567 100%
2009 10.191.615 -82.17%
2010 13.856.795 26.45%
2011 15.370.285 9.85%
2012 11.987.170 -28.22%
2013 17.434.867 31.25%
2014 22.161.962 21.33%
2015 28.669.329 22.7%
2016 14.256.873 -101.09%
2017 278.880 -5012.19%
2018 3.014.426 90.75%
2019 95.001 -3073.05%
2020 1.603.667 94.08%
2021 52.825.200 96.96%
2022 38.416.470 -37.51%
2023 1.554.000 -2372.1%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Health Empire Corporation Public Company Limited Equity
Year Equity Growth
2003 496.926.411
2004 1.044.799.109 52.44%
2005 1.005.666.234 -3.89%
2006 551.051.802 -82.5%
2007 148.479.761 -271.13%
2008 -118.355.602 225.45%
2009 -304.657.289 61.15%
2010 -360.698.925 15.54%
2011 -340.339.885 -5.98%
2012 -338.062.636 -0.67%
2013 199.243.356 269.67%
2014 202.113.309 1.42%
2015 275.514.397 26.64%
2016 177.149.418 -55.53%
2017 112.584.466 -57.35%
2018 47.281.084 -138.12%
2019 2.517.718 -1777.93%
2020 -21.834.055 111.53%
2021 1.229.786.973 101.78%
2022 956.574.189 -28.56%
2023 949.092.850 -0.79%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Health Empire Corporation Public Company Limited Assets
Year Assets Growth
2003 1.296.638.519
2004 2.013.227.052 35.59%
2005 2.232.277.131 9.81%
2006 1.779.237.057 -25.46%
2007 1.198.682.717 -48.43%
2008 1.007.169.544 -19.01%
2009 866.449.601 -16.24%
2010 435.227.243 -99.08%
2011 362.059.881 -20.21%
2012 683.884.321 47.06%
2013 690.732.498 0.99%
2014 382.159.760 -80.74%
2015 421.625.405 9.36%
2016 314.780.836 -33.94%
2017 220.900.030 -42.5%
2018 145.520.506 -51.8%
2019 95.135.453 -52.96%
2020 80.344.920 -18.41%
2021 1.425.586.596 94.36%
2022 1.031.492.006 -38.21%
2023 1.028.586.634 -0.28%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Health Empire Corporation Public Company Limited Liabilities
Year Liabilities Growth
2003 799.712.107
2004 968.427.942 17.42%
2005 1.226.610.896 21.05%
2006 1.228.185.255 0.13%
2007 1.050.202.956 -16.95%
2008 1.029.890.707 -1.97%
2009 1.073.380.896 4.05%
2010 493.612.223 -117.45%
2011 395.026.561 -24.96%
2012 713.055.329 44.6%
2013 179.949.183 -296.25%
2014 180.046.451 0.05%
2015 146.061.992 -23.27%
2016 137.618.286 -6.14%
2017 108.302.432 -27.07%
2018 98.239.421 -10.24%
2019 92.617.734 -6.07%
2020 102.178.975 9.36%
2021 195.799.622 47.81%
2022 74.917.817 -161.35%
2023 79.493.784 5.76%

Health Empire Corporation Public Company Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.03
Net Income per Share
-1.26
Price to Earning Ratio
-2.92x
Price To Sales Ratio
138.34x
POCF Ratio
-126.65
PFCF Ratio
-102.01
Price to Book Ratio
1.38
EV to Sales
142.47
EV Over EBITDA
-96.93
EV to Operating CashFlow
-140.07
EV to FreeCashFlow
-105.06
Earnings Yield
-0.34
FreeCashFlow Yield
-0.01
Market Cap
1,41 Bil.
Enterprise Value
1,45 Bil.
Graham Number
8.69
Graham NetNet
-0.18

Income Statement Metrics

Net Income per Share
-1.26
Income Quality
0.02
ROE
-0.47
Return On Assets
-0.44
Return On Capital Employed
-0.03
Net Income per EBT
1
EBT Per Ebit
17.81
Ebit per Revenue
-2.48
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
3.22
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.13
Operating Profit Margin
-2.48
Pretax Profit Margin
-44.11
Net Profit Margin
-44.08

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.03
Free CashFlow per Share
-0.04
Capex to Operating CashFlow
0.33
Capex to Revenue
-0.34
Capex to Depreciation
-0.34
Return on Invested Capital
-0.03
Return on Tangible Assets
-1.19
Days Sales Outstanding
356.84
Days Payables Outstanding
796.17
Days of Inventory on Hand
246.04
Receivables Turnover
1.02
Payables Turnover
0.46
Inventory Turnover
1.48
Capex per Share
-0.01

Balance Sheet

Cash per Share
0,02
Book Value per Share
2,66
Tangible Book Value per Share
0.83
Shareholders Equity per Share
2.66
Interest Debt per Share
0.13
Debt to Equity
0.05
Debt to Assets
0.04
Net Debt to EBITDA
-2.81
Current Ratio
0.62
Tangible Asset Value
0,30 Bil.
Net Current Asset Value
-0,05 Bil.
Invested Capital
0.05
Working Capital
-0,02 Bil.
Intangibles to Total Assets
0.63
Average Receivables
0,01 Bil.
Average Payables
0,01 Bil.
Average Inventory
5420911.5
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Health Empire Corporation Public Company Limited Dividends
Year Dividends Growth
2004 0
2005 0 0%

Health Empire Corporation Public Company Limited Profile

About Health Empire Corporation Public Company Limited

Health Empire Corporation Public Company Limited, through its subsidiaries, sells beauty products and provides beauty services. The company is involved in the sale of cosmetics and food supplement products, as well as food and beverage products for health and dietary needs. It also manufactures and distributes herbal, traditional medicinal, cosmeceutical, health and beauty treatment, and dietary supplement products. The company was formerly known as MPG Corporation Public Company Limited and changed its name to Health Empire Corporation Public Company Limited in May 2021. Health Empire Corporation Public Company Limited was founded in 1989 and is headquartered in Bangkok, Thailand.

CEO
Dr. Kumpol Buriyameathagul
Employee
0
Address
19 Soi Ramkhamhaeng 22 (Jittra Nukroh)
Bangkok, 10240

Health Empire Corporation Public Company Limited Executives & BODs

Health Empire Corporation Public Company Limited Executives & BODs
# Name Age
1 Mr. Sittichok Phiratamornphan
Chief Financial Officer
70
2 Dr. Kumpol Buriyameathagul
Acting Chief Executive Officer & Director
70
3 Ms. Thanatchaphan Thienthipsiri
Company Sec.
70
4 Ms. Karima Jaroonsakunwong
Company Sec.
70
5 Ms. Sukanya Kaewsa-ard
Accounting Mang.
70

Health Empire Corporation Public Company Limited Competitors